Table 1: Clinical profile of the subjects.

  Total tAMD PCV P Value (tAMD vs PCV)
Number of Patients 17 8 9 -
Age (years) 75.5 ± 4.8 75.3 ± 3.2 75.7 ± 5.9 *0.4328
Gender (Female/ Male) 6/11 1/7 5/4 **0.0882
Refraction (D) 0.2 ± 1.6 0.9 ± 1.1 -0.4 ± 1.8 *0.0564
LogMAR visual acuity 0.6 ± 0.5 0.5 ± 0.2 0.7 ± 0.7 *0.1479
Systemic Diseases
Hypertension 7 (41.2%) 3 (37.5%) 4 (44.4%) **0.5806
Diabetes 3 (17.6%) 1 (12.5%) 2 (22.2%) **0.5471
Hyperlipidemia 1 (5.8%) 0 (0.0%) 1 (11.1%) **0.5294
Coronary heart disease 0 (0.0%) 0 (0.0%) 0 (0.0%) **NA
Renal disease 0 (0.0%) 0 (0.0%) 0 (0.0%) **NA
Liver disease 0 (0.0%) 0 (0.0%) 0 (0.0%) **NA
Cerebrovascular disease 2(11.8%) 1(11.8%) 1(11.1%) **0.7352
Alcohol intake 1 (5.8%) 1 (12.5%) 2 (22.2%) **0.5471
Smoking 2(11.8%) 2 (25.0%) 2 (22.2%) **0.6647
Ocular Diseases
Cataract/IOL/Clear lens 11 /4 / 2 6 / 2 / 0 5 / 2 / 2 **0.3607
Glaucoma 0 (0.0%) 0 (0.0%) 0 (0.0%) **NA
Diabetic retinopathy 0 (0.0%) 0 (0.0%) 0 (0.0%) **NA

IOL= Intraocular lens. NA=Not applicable. *Unpaired Student’s t-test. **Chi-square test of independence or Fisher’s exact probability test.